Anil A Joy

Anil A Joy

UNVERIFIED PROFILE

Are you Anil A Joy?   Register this Author

Register author
Anil A Joy

Anil A Joy

Publications by authors named "Anil A Joy"

Are you Anil A Joy?   Register this Author

41Publications

680Reads

22Profile Views

Fine-mapping of a novel premenopausal breast cancer susceptibility locus at Chr4q31.22 in Caucasian women and validation in African and Chinese women.

Int J Cancer 2019 May 14. Epub 2019 May 14.

Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32407DOI Listing
May 2019

A prospective intervention to improve happiness and reduce burnout in oncologists.

Support Care Cancer 2019 Apr 30;27(4):1563-1572. Epub 2018 Nov 30.

Division of Medical Oncology, Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4567-5DOI Listing
April 2019

Filgrastim use in patients receiving chemotherapy for early-stage breast cancer-a survey of physicians and patients.

Support Care Cancer 2018 Jul 6;26(7):2323-2331. Epub 2018 Feb 6.

Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4074-8DOI Listing
July 2018

Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.

PLoS One 2017 7;12(8):e0182400. Epub 2017 Aug 7.

Department of Medical Genetics and Signal Transduction Research Group, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0182400PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546696PMC
October 2017

Dose-escalated Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Inoperable or Unresectable Non-Small Cell Lung Cancer.

Am J Clin Oncol 2017 Jun;40(3):294-299

*Department of Oncology, Division of Radiation Oncology †Department of Oncology, Division of Medical Oncology ‡Division of Medical Physics, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000140DOI Listing
June 2017

Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients.

Support Care Cancer 2017 06 27;25(6):1881-1886. Epub 2017 Jan 27.

Division of Medical Oncology and Department of Medicine, University of Ottawa, Ottawa, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3580-4DOI Listing
June 2017

Novel Methodology for Comparing Standard-of-Care Interventions in Patients With Cancer.

J Oncol Pract 2016 12 30;12(12):e1016-e1024. Epub 2016 Sep 30.

The Ottawa Hospital; University of Ottawa; Ottawa Hospital Research Institute, Ottawa; University of Alberta, Edmonton; and Kingston General Hospital, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.013474DOI Listing
December 2016

A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.

Clin Breast Cancer 2016 Apr 25;16(2):139-44.e1-3. Epub 2015 Sep 25.

Division of Medical Oncology, Cross Cancer Institute, Edmonton, AB, Canada; Division of Experimental Oncology, Cross Cancer Institute, Edmonton, AB, Canada; Department of Oncology, University of Alberta, Edmonton, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2015.09.006DOI Listing
April 2016

Biobanking in the Twenty-First Century: Driving Population Metrics into Biobanking Quality.

Adv Exp Med Biol 2015 ;864:95-114

Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-20579-3_8DOI Listing
March 2016

Discharge to Primary Care for Survivorship Follow-Up: How Are Patients With Early-Stage Breast Cancer Faring?

J Natl Compr Canc Netw 2015 Jun;13(6):762-71

From the Department of Oncology, University of Calgary, Tom Baker Cancer Centre; Department of Oncology, Division of Psychosocial Oncology, University of Calgary; and Psychosocial Resources, Tom Baker Cancer Centre, Calgary, Alberta, Canada, and the Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada. From the Department of Oncology, University of Calgary, Tom Baker Cancer Centre; Department of Oncology, Division of Psychosocial Oncology, University of Calgary; and Psychosocial Resources, Tom Baker Cancer Centre, Calgary, Alberta, Canada, and the Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0091DOI Listing
June 2015

Gastric Acid suppression is associated with decreased erlotinib efficacy in non-small-cell lung cancer.

Clin Lung Cancer 2015 Jan 15;16(1):33-9. Epub 2014 Aug 15.

Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2014.07.005DOI Listing
January 2015

HER story: the next chapter in HER-2-directed therapy for advanced breast cancer.

Oncologist 2013 8;18(11):1153-66. Epub 2013 Nov 8.

Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825298PMC
October 2014

De-escalated administration of bone-targeted agents in patients with breast and prostate cancer-A survey of Canadian oncologists.

J Bone Oncol 2013 Jun 15;2(2):77-83. Epub 2013 Apr 15.

Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada; Department of Medicine, University of Ottawa, Ottawa, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbo.2013.03.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723366PMC
June 2013

The global cancer epidemic: opportunities for Canada in low- and middle-income countries.

CMAJ 2012 Oct 10;184(15):1699-704. Epub 2012 Apr 10.

Women’s College Research Institute, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.111131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478354PMC
October 2012

Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer.

Clin Invest Med 2012 Oct 6;35(5):E271. Epub 2012 Oct 6.

Department of Oncology, Cross Cancer Institute and University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
October 2012

Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer.

J Clin Oncol 2011 Jun 9;29(18):2459-65. Epub 2011 May 9.

University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Ave, Second Floor, Box 1710, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.31.2975DOI Listing
June 2011

Exercise therapy across the lung cancer continuum.

Curr Oncol Rep 2009 Jul;11(4):255-62

Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
July 2009

Extending outcomes: epidermal growth factor receptor-targeted monoclonal antibodies in non-small-cell lung cancer.

Clin Lung Cancer 2009 Mar;10 Suppl 1:S24-9

Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2009.s.004DOI Listing
March 2009

Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls.

J Cancer Surviv 2008 Dec 16;2(4):275-82. Epub 2008 Oct 16.

Division of Applied Psychology, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-008-0070-1DOI Listing
December 2008

Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations.

Lancet Oncol 2008 Aug;9(8):757-65

Duke University Medical Centre, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(08)70195-5DOI Listing
August 2008

Skeletal health in postmenopausal survivors of early breast cancer.

Int J Cancer 2005 May;114(6):1010-5

Division of Medical Oncology, Department of Oncology, University of Alberta, Edmonton, Alberta T6G 1Z2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.20826DOI Listing
May 2005

Gastric adenocarcinoma: review and considerations for future directions.

Ann Surg 2005 Jan;241(1):27-39

Department of Surgery, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1356843PMC
http://dx.doi.org/10.1097/01.sla.0000149300.28588.23DOI Listing
January 2005